KaloBios Pharmaceuticals (KBIO) Prices 8.75M IPO at $8/Share

January 31, 2013 11:34 AM EST Send to a Friend
Get Alerts KBIO Hot Sheet
Trade KBIO Now!
Join SI Premium – FREE
KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) announced the pricing of its previously announced initial public offering of 8,750,000 shares of common stock at a price to the public of $8.00 per share, less underwriting discounts and commissions.

KaloBios has granted the underwriters a 30-day option to purchase up to 1,312,500 additional shares of common stock at the same price to cover over-allotments, if any. KaloBios' common stock will trade on the NASDAQ Global Market under the symbol "KBIO."

Leerink Swann LLC is serving as sole book-running manager for the offering. William Blair & Company, L.L.C. is serving as the lead manager and Needham & Company LLC is serving as co-manager.

A registration statement relating to these securities has been declared effective by the SEC. The offering will be made only by means of a prospectus..


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, IPOs

Related Entities

William Blair, Needham & Company

Add Your Comment